cyc 202 has been researched along with casein kinase ii in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (casein kinase ii) | Trials (casein kinase ii) | Recent Studies (post-2010) (casein kinase ii) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 3,268 | 5 | 1,299 |
| Protein | Taxonomy | cyc 202 (IC50) | casein kinase ii (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | 3.57 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.484 | |
| Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 2.23 | |
| Cyclin-A2 | Homo sapiens (human) | 2.38 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 2.38 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 2.23 | |
| Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 2.23 | |
| Cyclin-A1 | Homo sapiens (human) | 2.38 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.26 | |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
| David-Pfeuty, T; Hernandez-Verdun, D; Nouvian-Dooghe, Y; Roussel, P; Sirri, V | 1 |
1 review(s) available for cyc 202 and casein kinase ii
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
1 other study(ies) available for cyc 202 and casein kinase ii
| Article | Year |
|---|---|
Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.
Topics: Casein Kinase II; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Cell Nucleolus; Cell Nucleus; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Dichlororibofuranosylbenzimidazole; Enzyme Inhibitors; Gene Expression Regulation; Humans; Mitomycin; Models, Biological; Protein Serine-Threonine Kinases; Purines; Ribosomes; RNA, Ribosomal; Roscovitine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |